- Home
- TR vs FOLD Comparison
TR vs FOLD Comparison
Compare TR & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TR
- FOLD
- Stock Information
- Founded
- TR 1896
- FOLD 2002
- Country
- TR United States
- FOLD United States
- Employees
- TR N/A
- FOLD N/A
- Industry
- TR Specialty Foods
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- TR Consumer Staples
- FOLD Health Care
- Exchange
- TR Nasdaq
- FOLD Nasdaq
- Market Cap
- TR 2.9B
- FOLD 2.9B
- IPO Year
- TR N/A
- FOLD 2007
- Fundamental
- Price
- TR $38.66
- FOLD $7.40
- Analyst Decision
- TR
- FOLD Strong Buy
- Analyst Count
- TR 0
- FOLD 10
- Target Price
- TR N/A
- FOLD $26.89
- AVG Volume (30 Days)
- TR 184.2K
- FOLD 4.5M
- Earning Date
- TR 07-24-2025
- FOLD 07-31-2025
- Dividend Yield
- TR 0.94%
- FOLD N/A
- EPS Growth
- TR N/A
- FOLD N/A
- EPS
- TR 1.24
- FOLD N/A
- Revenue
- TR $722,849,000.00
- FOLD $571,160,000.00
- Revenue This Year
- TR N/A
- FOLD $19.97
- Revenue Next Year
- TR N/A
- FOLD $22.92
- P/E Ratio
- TR $31.16
- FOLD N/A
- Revenue Growth
- TR N/A
- FOLD 25.35
- 52 Week Low
- TR $27.14
- FOLD $5.51
- 52 Week High
- TR $40.43
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- TR 55.04
- FOLD 69.27
- Support Level
- TR $38.31
- FOLD $6.61
- Resistance Level
- TR $40.03
- FOLD $7.07
- Average True Range (ATR)
- TR 0.89
- FOLD 0.31
- MACD
- TR -0.15
- FOLD 0.08
- Stochastic Oscillator
- TR 47.83
- FOLD 98.66
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.